Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Aruna to Abhaya: 50 Years of Silence in Protecting Healthcare Professionals.

Asian bioethics review·2026
Same author

Study of the Impact of Radioactivity Detection on the Water Distribution Network Versus the Installation of an Early Warning Network.

Sensors (Basel, Switzerland)·2026
Same author

Development and psychometric evaluation of an abbreviated form of the revised suicide crisis inventory (A-SCI)-2 in major depression: A multicentric investigation.

Asian journal of psychiatry·2026
Same author

Age of onset and course and outcome of bipolar disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study).

Indian journal of psychiatry·2025
Same author

Human Apolipoprotein E ε4 Allele Modulates Energy Substrate Availability, Seizure Burden, Mortality and Hippocampal Injury, Cell Death, and Inflammation after Neonatal Hypoxic-Ischemic Brain Injury.

Developmental neuroscience·2025
Same author

Determining the Ground Reaction Force Value and Location for Each Foot During Bipedal Stance Exercises from a Single Forceplate.

Sensors (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 3, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Mild cognitive impairment: The dilemma.

Charles Pinto1, Alka A Subramanyam

  • 1Department of Psychiatry, TN Medical College and BYL Nair Hospital, Mumbai - 400008, India.

Indian Journal of Psychiatry
|March 19, 2011
PubMed
Summary

Mild cognitive impairment (MCI) affects many older adults, increasing dementia risk. Early detection and management, including risk factor control and new therapies, are crucial for better outcomes.

Keywords:
Cognitioncriteriadiagnosismedicationsmemorynomenclaturerisk factors

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Related Experiment Videos

Last Updated: Jun 3, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Area of Science:

  • Neurology
  • Geriatrics
  • Cognitive Science

Background:

  • Memory complaints are common in aging populations, raising concerns about progression to dementia.
  • Mild cognitive impairment (MCI) is recognized as a potential precursor stage to dementia.
  • Varied nomenclature and diagnostic criteria necessitate standardized approaches.

Purpose of the Study:

  • To highlight the prevalence and conversion rates of MCI to dementia.
  • To emphasize the need for improved diagnostic tools and biomarkers for MCI.
  • To discuss current and emerging treatment strategies for MCI and Alzheimer's Disease.

Main Methods:

  • Review of existing literature on MCI prevalence, diagnosis, and management.
  • Analysis of diagnostic criteria from organizations like the American Academy of Neurology and EADC.
  • Examination of treatment responses to Alzheimer's Disease medications and non-pharmacological interventions.

Main Results:

  • MCI prevalence varies widely (3-59%), with 8-15% converting to dementia.
  • Neuropsychological tests, neuroimaging, and biological markers are essential for MCI detection.
  • Current Alzheimer's Disease medications show limited long-term efficacy in MCI, prompting research into disease-modifying drugs.

Conclusions:

  • Coordinated efforts are needed to enhance the detection and management of MCI.
  • Integrating risk factor management (hypertension, diabetes) and non-pharmacological approaches (exercise, social networking) is vital.
  • Further research into disease-modifying drugs offers promise for future MCI and dementia treatment.